NATICK, Mass., Feb. 1, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces first patient use and European market launch of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium ...

Boston Scientific is scheduled to release its fourth quarter and fiscal 2011 earnings on Thursday, February 2, 2012, before the market opens.

Wall Street is expecting lower profit for Boston Scientific (BSX) when the company reports its fourth quarter results on Thursday, February 2, 2012. Analysts are expecting earnings per share of 8 cents after the company booked a profit of 20 cents a share a year earlier.

LONDON, January 26, 2012 /PRNewswire/ --NICE Report Supports Safety and Effectiveness of Alair ® System Boston Scientific (UK) welcomes new guidance from the National Institute for Health and Clinical ...

NEW YORK (MarketWatch) -- Boston Scientific Corp. said Monday it received a positive ruling in a patent infringement case with Johnson Johnson involving stents used for heart patients. Boston Scientific said the U.S. District Court for the New Jersey has found all the asserted patents in a 2008 suit brought by by Johnson Johnson to be invalid. The company said the court entered judgement in ...